These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5128066)

  • 21. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative study of 2 therapeutic schemes in pulmonary tuberculosis not previously treated].
    Galleguillos F; Valenzuela P; Carrasco E; Ham O; Ihnen R
    Rev Med Chil; 1973 Jan; 101(1):25-9. PubMed ID: 4753547
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug therapy of pulmonary tuberculosis].
    Ludes H
    Dtsch Med Wochenschr; 1972 Feb; 97(8):289-91. PubMed ID: 5058425
    [No Abstract]   [Full Text] [Related]  

  • 24. Rifampin-isoniazid compared with PAS-isoniazid-streptomycin in initial treatment of pulmonary tuberculosis. A controlled cooperative trial.
    Boman G
    Chest; 1972 Jun; 61(6):533-8. PubMed ID: 5032151
    [No Abstract]   [Full Text] [Related]  

  • 25. Duration of allergy to antituberculous drugs (PAS, SM and INH) in tuberculous patients.
    Brown H; Jennings TS; Coleman EO; Bulubash V
    Med Ann Dist Columbia; 1966 Dec; 35(12):652-7 passim. PubMed ID: 5231829
    [No Abstract]   [Full Text] [Related]  

  • 26. [Rifampicin in the treatment of lung and kidney tuberculosis].
    Kraan JK; Mulder RJ; Mulder-De Jong MT; van Dijk B
    Ned Tijdschr Geneeskd; 1972 Jan; 116(1):9-15. PubMed ID: 4555064
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug intolerance and depressive states in tubercular patients].
    Scherding JP; Suerinck E
    Rev Tuberc Pneumol (Paris); 1967; 31(1):55-60. PubMed ID: 6037247
    [No Abstract]   [Full Text] [Related]  

  • 28. [Electroencephalographic changes and antitubercular treatments].
    Piéron R; Gautier H; Duhurt J; Kauffmann JP
    Sem Hop; 1972 Oct; 48(40):2585-91. PubMed ID: 4344846
    [No Abstract]   [Full Text] [Related]  

  • 29. [[Comparative studies on therapeutic effects of SM.INH.PAS, SM.INH.PAS.EB twice weekly, and SM.INH.PAS.EB daily in original treatment cases of pulmonary tuberculosis].
    Kekkaku; 1971 Aug; 46(8):325-33. PubMed ID: 4998863
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rheumatic diseases caused by antitubercular drugs].
    Anastasatu C; Stoia I; Kaufman S; Ghenoiu O; Iancovici O
    Z Erkr Atmungsorgane Folia Bronchol; 1972 Jan; 136(1):51-63. PubMed ID: 4538033
    [No Abstract]   [Full Text] [Related]  

  • 31. [Diabetes mellitus and pulmonary tuberculosis].
    Alimpić D; Popović S
    Z Erkr Atmungsorgane Folia Bronchol; 1970; 132(2):187-94. PubMed ID: 5203360
    [No Abstract]   [Full Text] [Related]  

  • 32. [Critical study of antibiotic tests systematically performed before treatment of pulmonary tuberculous patients].
    Benda R; Le Guillou F
    Sem Ther; 1965 Jan; 41(1):19-21. PubMed ID: 5879027
    [No Abstract]   [Full Text] [Related]  

  • 33. [The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].
    Knop P; Kindler U; Merholz T
    Med Welt; 1976 Feb; 27(8):389-90. PubMed ID: 1256308
    [No Abstract]   [Full Text] [Related]  

  • 34. The detection of streptomycin, PAS and isoniazid resistant tubercle bacilli by the direct method.
    Stewart SM; Burnet ME
    Tubercle; 1968 Jun; 49(2):217-25. PubMed ID: 4969697
    [No Abstract]   [Full Text] [Related]  

  • 35. The management of hypersensitivity reactions to antituberculosis drugs.
    Thompson JE
    Med J Aust; 1969 Nov; 2(21):1058-63. PubMed ID: 5373732
    [No Abstract]   [Full Text] [Related]  

  • 36. [The algodystrophies caused by antituberculous chemotherapy. Study of 24 cases].
    Renier JC; Oury M; Bregeon C; Tuchais E
    Rev Rhum Mal Osteoartic; 1969 Nov; 36(11):605-7. PubMed ID: 5367163
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acute renal failure following para-aminosalicylic-acid therapy].
    Csata S; Szendi L; Koller O
    Acta Chir Acad Sci Hung; 1975; 16(2):151-4. PubMed ID: 1227221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombocytopenia following administration of para-aminosalicylic acid.
    Feigin RD; Zarkowsky HF; Shearer W; Anderson DC
    J Pediatr; 1973 Sep; 83(3):502-3. PubMed ID: 4541998
    [No Abstract]   [Full Text] [Related]  

  • 39. [Frequency of side-effects of tuberulostatics and its relation to the applied combination].
    Bethge W
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):258-65. PubMed ID: 4302238
    [No Abstract]   [Full Text] [Related]  

  • 40. [ON SOME CHANGES OF THE BLOOD CELL COMPOSITION IN ADULT TUBERCULOSIS PATIENTS].
    MIKHAILOV FA
    Klin Med (Mosk); 1963 Aug; 41():70-5. PubMed ID: 14086893
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.